# Better Leukemia Diagnostics Through AI (BELUGA)

> **NCT04466059** · — · RECRUITING · sponsor: **Munich Leukemia Laboratory** · enrollment: 25000 (estimated)

## Conditions studied

- Hematologic Malignancy
- Leukemia
- Minimal Residual Disease
- Lymphoma
- Blood Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Automated AI-Guided Diagnosis of Hematological Malignancies

## Key facts

- **NCT ID:** NCT04466059
- **Lead sponsor:** Munich Leukemia Laboratory
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-05
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 25000 (ESTIMATED)
- **Last updated:** 2024-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04466059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04466059, "Better Leukemia Diagnostics Through AI (BELUGA)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04466059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*